Literature DB >> 953752

Regional concentrations of noradrenaline and dopamine in rat brain.

D H Versteeg, J Van Der Gugten, W De Jong, M Palkovits.   

Abstract

The concentrations of noradrenaline and lopamine of 92 brain regions have been measured by a radiometric method which enabled discrimination between noradrenaline and adrenaline. Almost all brain regions investigated contained both noradrenaline and lopamine in measurable amount. However, both catecholamines appeared to be unevenly distributed. Very high dopamine concentrations were measured in the olfactory tubercle, the nucleus accumbens, the caudate nucleus and the rostral part of the medial forebrain bundle; the globus pallidus, the nucleus tractus diagonalis and the nucleus septalis lateralis were also very rich in dopamine. Outside the telencephalon the dopamine concentrations were rather low, except in the median eminence and the area tegmentalis ventralis (Tsai), an area corresponding to the A10 region. High noradrenaline concentrations were measured in most hypothalamic nuclei. Relatively high concentrations of this catecholamine were also measured in several mesencephalic (the ventral part of the central gray, the nucleus raphe dorsalis and the nucleus cuneiformis) and pontine (the locus coeruleus and the nuclei parabrachiales) regions. The highest noradrenaline concentrations in the medulla oblongata were observed in the A2 region and the nucleus commissuralis, which contained at least twice as much noradrenaline as did the more rostral part of the nucleus tractus solitarii.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 953752     DOI: 10.1016/0006-8993(76)90057-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  55 in total

1.  Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.

Authors:  Masato Hara; Ryuichi Fukui; Eriko Hieda; Mahomi Kuroiwa; Helen S Bateup; Tatsuhiko Kano; Paul Greengard; Akinori Nishi
Journal:  J Neurochem       Date:  2010-03-04       Impact factor: 5.372

2.  Behavioural characterization of neuroleptic properties in the rodent.

Authors:  B Costall; R J Naylor
Journal:  Proc R Soc Med       Date:  1977

3.  L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions.

Authors:  Joseph M Breier; Michael G Bankson; Bryan K Yamamoto
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

4.  Monoamines and their metabolites in somatosensory, visual, and cingulate cortices of adult rat: differences in content and lack of sidedness.

Authors:  N J Kabani; T A Reader; R W Dykes
Journal:  Neurochem Res       Date:  1990-10       Impact factor: 3.996

5.  Electron-microscopic cytochemistry of the catecholaminergic innervation of TRH neurons in the rat hypothalamus.

Authors:  S Shioda; Y Nakai; A Sato; S Sunayama; Y Shimoda
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

6.  Real-time monitoring of electrically evoked catecholamine signals in the songbird striatum using in vivo fast-scan cyclic voltammetry.

Authors:  Amanda R Smith; Paul A Garris; Joseph M Casto
Journal:  J Chem Neuroanat       Date:  2015-04-18       Impact factor: 3.052

7.  Degeneration of two of nine types of synapses in the putamen after center median coagulation in the cat.

Authors:  J W Chung; R Hassler; A Wagner
Journal:  Exp Brain Res       Date:  1977-06-27       Impact factor: 1.972

8.  Demonstration by the Fink-Heimer impregnating method of a ventral mesencephalic-locus coeruleus projection in the rat.

Authors:  H Simon; M Le Moal
Journal:  Experientia       Date:  1977-05-15

9.  Involvement of catecholamines in Haemophilus influenzae induced decrease of beta-adrenoceptor function.

Authors:  A J Schreurs; D H Versteeg; F P Nijkamp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-09       Impact factor: 3.000

10.  Regional tyrosine levels in rat brain after tyrosine administration.

Authors:  M C Morre; F Hefti; R J Wurtman
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.